New Study: COVID Survival Rate For Those Under 20 is 99.9987%
97.1% of over 70s not in care homes survive.
Paul Joseph Watson
Top epidemiologist Professor John Ioannidis has published a new study which concludes that the survival rate of people under the age of 20 who catch COVID is 99.9987%.
The data used from the study was taken before the advent of mass vaccination programs, meaning the numbers apply to unvaccinated people.
Ioannidis previously published an analysis of seroprevalence (antibody) studies from 2020, which resulted in him being able to reveal that the infection fatality rate for COVID globally was around 0.15%. In Europe, the number stood at 0.3%-0.4% , while in Africa and Asia it went down to 0.05%.
Now the professor has published new information that breaks down infection fatality rates by age.
“From analysis of 25 seroprevalence surveys across 14 countries, Prof. Ioannidis and his colleague found the IFR varied from 0.0013% in the under-20s (around one in 100,000) to 0.65% in those in their 60s,” writes Will Jones.
For those above 70 not in a care home it was 2.9%, rising to 4.9% for all over-70s. This means that even for the elderly, more than 95% of those infected survive – 97.1% when considering those not in a care home. For younger people the mortality risk is orders of magnitude less, with 99.9987% of under-20s surviving a bout of the virus. These survival rates include people with underlying health conditions, so for the healthy the rates will be higher again (and the fatality rates lower).”
The authors of the study concluded that the data reflects the reality that the infection fatality rate of COVID is substantially lower than previously reported estimates.
“The study’s findings confirm that Covid is a mild disease in all but a small minority of cases. With Omicron now reducing the severity several-fold further, even the proponents of lockdown should be able to accept that this virus is well below a level where restrictions are justifiable,” writes Jones.
The results of the study once again bring into question the rationality of giving COVID-19 vaccines to young people and children.
(TLB) published this article from Summit News as compiled and written by Paul Joseph Watson
Brand new merch now available! Get it at https://www.pjwshop.com/
In the age of mass Silicon Valley censorship It is crucial that we stay in touch. We need you to sign up for our free newsletter here. Support our sponsor – Turbo Force – a supercharged boost of clean energy without the comedown. Also, we urgently need your financial support here.
Header featured image (edited) credit: Ioannidis photo via YouTube; illustration by Undark
Emphasis added by (TLB) editors
Stay tuned to …
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.